111, Inc. Overview
Pro stress-test →111, Inc. operates an integrated online and offline platform in the healthcare market in China through B2C and B2B segments. The company, co-founded in 2010, digitally connects patients with drugs and healthcare services to build the largest healthcare platform in China.
Strategic Profile
Pro stress-test →Through its S2B2C business model, 111 leverages technology to enable businesses to serve customers better across its omni-channel platform. In 2024, the company achieved 14.40 billion RMB in revenue and achieved its first-ever annual operating profit.
Competitive Landscape
Pro stress-test →111 operates an integrated online and offline healthcare platform in China, selling medical and wellness products through online retail and pharmacy networks while providing online consultation and prescription services. Main competitors include other digital health platforms in China's healthcare e-commerce space, though 111 differentiates through its omni-channel model combining B2B wholesale, B2C retail, and virtual pharmacy networks.
Industry Context
111, Inc. operates in Digital Healthcare / Healthcare E-commerce.
Key facts
Founded: 2010 · Headquarters: Shanghai, China · Revenue: 14.40B RMB · Market cap: $0.069B